Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. [Phase 2]
An ongoing Phase 2 trial evaluates an irinotecan-based triplet (FOLFOXIRI) as perioperative therapy for resectable gastric and gastroesophag…